Targeting initial tumour-osteoclast spatiotemporal interaction to prevent bone metastasis

Area of Science:

• Oncology
• Biomaterials Science
• Cell Biology

Background:

• Bone is a frequent site for cancer metastasis.
• Early-stage metastasis is challenging to treat due to low cell proliferation and immune evasion.
• Tumor microenvironment interactions offer potential targets for early intervention.

Purpose of the Study:

• To investigate the spatiotemporal interaction between tumor cells and osteoclasts in bone metastasis.
• To identify and characterize a novel tumor-associated osteoclast subtype.
• To develop and validate a targeted therapeutic strategy for early bone metastasis prevention.

Main Methods:

• Identification and characterization of tumor-associated osteoclasts (tumasteoclasts) induced by tumor-migrasome-mediated cytoplasmic transfer.
• Design and synthesis of tetracycline-modified nanoliposomes encapsulating sodium bicarbonate and sodium hydrogen phosphate.
• In situ evaluation of the nanoliposome's efficacy in decoupling tumasteoclasts and killing tumor cells.

Main Results:

• A novel osteoclast subtype, 'tumasteoclast,' was identified, crucial for bone metastasis progression.
• The developed nanoliposomes specifically release hydrogen phosphate ions upon tumasteoclast interaction.
• This ion release depletes calcium, forms crystals, inhibits migrasome formation, and disrupts tumor cell membranes, preventing metastasis.

Conclusions:

• Tumasteoclasts play a critical role in the early stages of bone metastasis.
• The proposed in situ decoupling-killing strategy using functionalized nanoliposomes is effective in preventing early bone metastasis.
• This study establishes a new model for studying tumor cell behavior and offers a proof-of-concept for behavior-targeting therapies.